LL

February 12, 2019
Published by LL at February 12, 2019
Categories

New Scientific Research provides link between Globo-series glycosphingolipids (GSLs) antigens and tumor survival in Breast Cancer

[…]
Do you like it?0
Read more
April 19, 2018
Published by LL at April 19, 2018
Categories

OBI Pharma Announces FDA Clearance of OBI-3424 IND Application for A Phase I/II Study Targeting AKR1C3 Solid Tumors

[…]
Do you like it?0
Read more
December 22, 2017
Published by LL at December 22, 2017
Categories

OBI Pharma announces participation at the 36th J.P. Morgan Annual Healthcare Conference in San Francisco from January 8-10, 2018.

[…]
Do you like it?0
Read more
October 5, 2015
Published by LL at October 5, 2015
Categories

OBI Pharma Enters Exclusive Agreement with MSD for Rights to DIFICID® (fidaxomicin) in Taiwan

[…]
Do you like it?0
Read more
12345
Next page